Comparison of Two Treatment Strategies in Hypertensive Patients

Novartis4,445 enrolled

Overview

The purpose of the study is to determine whether a specific training of General Practitioners (Family Physicians) regarding the new official guidelines for the treatment of hypertension results in a higher control of high Blood pressure in their patient population.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

4,445

Conditions

Hypertension

Interventions

Medical educationBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * • Male or female patients \>18 years of age * Hypertension defined by MSDBP ≥ 90 and /or MSSBP ≥ 140 mmHg for untreated patients, patients on diet and exercise, patients on current anti-hypertensive monotherapy or bitherapy treatment who remain uncontrolled or patients experiencing unacceptable side-effects, Exclusion Criteria: * • Severe hypertension, secondary hypertension, type 1 diabetes mellitus * History of congestive heart failure, unstable coronary insufficiency, life threatening arrhythmia, significant valvular disease, second or third degree heart block etc. * Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Blood pressure less than 140/90 mmHg in non-diabetic patients, or less than 130/80 mmHg in patients with diabetes or kidney disease, after 8 weeks

Secondary Outcomes

Change from baseline systolic blood pressure after 8 weeks

Change from baseline diastolic blood pressure after 8 weeks

Diastolic blood pressure less than 90 mmHg or reduction in diastolic blood pressure greater than 10 mmHg

Systolic blood pressure less than 140 mmHg or reduction in diastolic blood pressure greater than 15 mmHg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.